Pacific Biosciences of California, Inc. PACB
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Eve Burstein | Bernstein | 1.335 $ | 1.7 $ | 0.37 % | 08/08/2025 |
| Luke Sergott | Barclays | 1.22 $ | 1.5 $ | 0.28 % | 25/06/2025 |
| Tycho Peterson | Jefferies | 1.79 $ | 4 $ | 2.21 % | 03/06/2024 |
| Tejas Savant | Morgan Stanley | 1.975 $ | 4 $ | 2.03 % | 13/05/2024 |
| David Westenberg | Piper Sandler | 1.77 $ | 2 $ | 0.23 % | 13/05/2024 |
| Luke Sergott | Barclays | 1.72 $ | 2 $ | 0.28 % | 10/05/2024 |
| Matthew Sykes | Goldman Sachs | 1.4 $ | 2.5 $ | 1.10 % | 18/04/2024 |
| Kyle Mikson | Canaccord Genuity | 1.4 $ | 3.5 $ | 2.10 % | 16/04/2024 |
| David Westenberg | Piper Sandler | 7.61 $ | 7.5 $ | -0.11 % | 17/08/2022 |
| David Westenberg | Piper Sandler | 5.84 $ | 6 $ | 0.16 % | 15/05/2022 |
| David Westenberg | Piper Sandler | 14.45 $ | 20 $ | 5.55 % | 12/01/2022 |